Walgreens Boots Alliance Inc. reported on Thursday that its sales from continuing operations stood at $32.4 billion in the fourth quarter of fiscal 2022 after declining 5.3% from the same period the prior year.

In the final trimester of 2022, operating loss landed at $822 million, down from an operating income of $910 million from a year ago. The diluted net loss per common share from continuing operations was $0.48 after the company had diluted net earnings per share (EPS) of $0.41 in the fourth three-month period of 2022.

As for the results for the full fiscal 2022, sales from continuing operations rose 0.1% from 2021 to $132.7 billion, operating income decreased 41% to $1.39 billion, while diluted net EPS from continuing operations more than doubled to $5.01.

Company shares were up 6.48% in the premarket in light of the report.